Effect of gamma conglutin treatment on JNK1 gene expression and protein activation in a rat model of type 2 diabetes.

Context: Gamma conglutin (Cγ) from lupine species represents a potential complementary treatment for type 2 diabetes mellitus (T2DM) because of its hypoglycaemic effect. However, its underlying mechanism of action is not fully known.

Objective: To evaluate whether Cγ from M.